ARCH Venture Fund X, L.P. bought $10.0M of SANA
owner at Sana Biotechnology, Inc.. 1,818,181 shares at an average of $5.50, traded Feb 8, 2024, filed Feb 12, 2024.
Score components
- +12Role10% owner
- +25Trade size$10.0M at market
- +3Relative to holdingsHoldings up 18%
- +4Price context18% below the 52-week high
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-24-002840, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 8, 2024 | POpen-market purchase Common Stockindirect: See Footnote | +363,637 | $5.50 | $2.0M | 10,667,387 | Feb 12, 2024 |
| Feb 8, 2024 | POpen-market purchase Common Stockindirect: See Footnote | +727,272 | $5.50 | $4.0M | 12,446,022 | Feb 12, 2024 |
| Feb 8, 2024 | POpen-market purchase Common Stockindirect: See Footnote | +727,272 | $5.50 | $4.0M | 12,446,022 | Feb 12, 2024 |
Related signals
Other insiders at Sana Biotechnology, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 37Weak | SANAsell Sana Biotechnology, Inc. | Fmr LLC owner, other | $1.9M 290,912 shares | -6% | |
| 33Weak | SANAsell Sana Biotechnology, Inc. | Patrick Y Yang director | $236k 25,000 shares | -14% | |
| 54Moderate | Sana Biotechnology, Inc. | Keith Crandell owner | $10.0M 1,818,181 shares | +18% | |
| 62Notable | Sana Biotechnology, Inc. | Robert Nelsen director, owner | $10.0M 1,818,181 shares | +18% | |
| 9Weak | Sana Biotechnology, Inc. | Christian Hordo EVP, Chief Business Officer | $300k 75,000 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.